As of 2026-03-24, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (36.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.93 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -275.2%.
The range of the Relative Valuation is (35.84) - (37.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.5x - 41.3x | 38.2x |
| Forward P/E multiples | 25.8x - 34.7x | 30.3x |
| Fair Price | (35.84) - (37.19) | (36.66) |
| Upside | -271.2% - -277.7% | -275.2% |
| Date | P/E |
| 2026-03-13 | -20.15 |
| 2026-03-12 | -19.90 |
| 2026-03-11 | -18.69 |
| 2026-03-10 | -18.17 |
| 2026-03-09 | -17.05 |
| 2026-03-06 | -16.95 |
| 2026-03-05 | -17.36 |
| 2026-03-04 | -16.91 |
| 2026-03-03 | -16.77 |
| 2026-03-02 | -17.61 |
| 2026-02-27 | -17.50 |
| 2026-02-26 | -18.02 |
| 2026-02-25 | -17.95 |
| 2026-02-24 | -17.74 |
| 2026-02-23 | -18.86 |
| 2026-02-20 | -20.01 |
| 2026-02-19 | -23.43 |
| 2026-02-18 | -23.78 |
| 2026-02-17 | -22.11 |
| 2026-02-13 | -21.50 |
| 2026-02-12 | -21.86 |
| 2026-02-11 | -23.59 |
| 2026-02-10 | -22.35 |
| 2026-02-09 | -22.62 |
| 2026-02-06 | -19.38 |
| 2026-02-05 | -12.79 |
| 2026-02-04 | -14.12 |
| 2026-02-03 | -13.12 |
| 2026-02-02 | -12.81 |
| 2026-01-30 | -12.92 |
| 2026-01-29 | -12.72 |
| 2026-01-28 | -12.66 |
| 2026-01-27 | -13.38 |
| 2026-01-26 | -13.38 |
| 2026-01-23 | -14.10 |
| 2026-01-22 | -13.59 |
| 2026-01-21 | -13.41 |
| 2026-01-20 | -12.92 |
| 2026-01-16 | -13.31 |
| 2026-01-15 | -13.17 |
| 2026-01-14 | -13.36 |
| 2026-01-13 | -13.22 |
| 2026-01-12 | -13.61 |
| 2026-01-09 | -13.54 |
| 2026-01-08 | -13.75 |
| 2026-01-07 | -14.20 |
| 2026-01-06 | -13.70 |
| 2026-01-05 | -13.64 |
| 2026-01-02 | -12.51 |
| 2025-12-31 | -12.83 |